Unfortunately, we did not have sufficient CSF to validate and run the BRP-39 assays but speculate that BRP-39 is likely to be raised in the CSF of Huntington’s disease mice and to correlate with NEFL and total-Tau levels. This evidence concerns the gene MAPT and Huntington disease.